A comprehensive pan-cancer analysis of LRFN4: its potential as a prognostic biomarker and therapeutic target for immunotherapy

A comprehensive pan-cancer analysis of LRFN4: its potential as a prognostic biomarker and therapeutic target for immunotherapy

BackgroundLRFN4, characterized by leucine-rich repeats and fibronectin type III domains, has been implicated in various human diseases. However, its role in immune regulation and cancer prognosis remains unclear.MethodsWe performed a comprehensive analysis using datasets from The Cancer Genome Atlas...

Full description

Saved in:
Bibliographic Details
Main Authors: Yinmei Xu, Xin Wu, Peng Zhi, Genyu Guo, Yankan Fu, Lukuan You, Siyuan Huai, Jianxiong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
LRFN4
pan-cancer analysis
TCGA
immunotherapy
tumor microenvironment
prognostic biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1539076/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1539076/full

Similar Items